Skip to main content

Panic Disorder clinical trials at UC Health
2 in progress, 1 open to eligible people

  • Optimizing Exposure Therapy for Anxiety Disorders

    open to eligible people ages 18-65

    The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.

    at UCLA

  • The Role of Orexin in Human Panic Disorder

    Sorry, in progress, not accepting new patients

    The purpose of this study is to provide some information (pilot data) about whether the study drug, suvorexant, (1) affects levels of orexin in people with panic disorder, and (2) is associated with decreased panic symptoms in response to a carbon dioxide (CO2) challenge.

    at UCSF

Last updated: